Product information for optical people.
Issue link: http://vcpn.epubxp.com/i/660898
APRIL 2016 // 105 VISIONCAREPRODUCTS.COM VCPN Rodriguez said. "The most damaging blue light is in the 400-440 nm range. This is our focus for fltering out bad blue light. The selective feature allows us to turn the blocker off to allow the good blue light above 460 nm through to the human eye, which is needed by the body to set our circadian rhythm and sleep patterns," explained Rod- riguez. "The selective capability is the true separator in our intellectual properties and technology at HPO." HPO doesn't sell lenses or mono- mers and doesn't treat lenses. It licens- es technologies to HPO's partners. Those partners then develop products covered and protected by the patent claims or can choose to use technolo- gies that HPO has already developed. Rodriquez reports that HPO has oph- thalmic partners who have provided selective blue fltering protection under HPO patents for millions of patients worldwide. HPO is also working outside the op- tical space on aerospace and military applications and with lighting manu- facturers, auto and building glass producers and some of the largest companies in the world where protec- tion is needed to reduce damage from harmful blue light. "Our mission is not just about blue light protection in optical lenses," he said. "Our mission is to identify every space where blocking harmful blue light is benefcial to the human body while not interrupting other body functions." The technology that HPO offers creates lenses that are essentially colorless. This is in contrast to blue light fltering lenses from other com- panies that have signifcant residual color. "Our technology doesn't flter all or a major portion of the blue light spectrum like some others do. Instead, we focus on removing 20% to 25% of a select portion within the blue light spectrum. This makes our lenses almost colorless for all practical purposes. Published, peer-reviewed studies indicate that this level of blocking reduces retinal cell death by 35% to 50%," Rodriguez pointed out. He also added that the colorlessness of the lenses was a major feature of their success. HPO lenses range from 3 to 4 on the ASTM Yellowness Test. This is Andrew Ishak, OD, FAAO, originally focused on inventing technology for sun protection in varying light condi- tions when he founded High Perfor- mance Optics (HPO). With rising evidence that high energy visible, or blue, light was a factor in age-related macular degeneration, he shifted his focus to researching other applica- tions for managing light. Today, as chief visionary offcer for HPO, he col- laborates with other companies and industries to bring blue light protec- tion to consumers in varying forms. HPO's president and CEO, Larry Rodriguez proudly pointed out that HPO holds many issued and pend- ing patents worldwide for selective fltering of blue light in various meth- odologies, including absorption, refection, interference, scattering or combinations of these. Recently, the company has further refned the absorptive technology for several oph- thalmic and non-ophthalmic global companies. Rodriguez explained that HPO's fltering technology differs from other blue light lens technologies because it selectively flters the wavelengths in the blue portion of the visible spec- trum. "There are many products on the market that are broadband flters," in stark contrast to lenses with scores of 18, 40 and higher. When asked about Apple's move to enable iPhone users to adjust their screen to reduce blue light, Rodriguez said, "I am in favor of anything that will help protect consumers from high energy visible light without interrupt- ing other body functions. Our mission is to protect the eye and body from harmful blue light, and that can be accomplished through various product applications." As more evidence emerges about the harm high energy visible, blue light can cause the eyes, HPO is positioned in a business sector that has huge growth potential. Reaching outside the ophthalmic space further indi- cates the company's dedication to its mission. Ed De Gennaro MEd, ABOM, is director, professional content of First Vision Media Group. Bi z SOLUTIONS WHERE TO FIND IT: High Performance Optics Hpousa.com • email@example.com